1993
DOI: 10.1016/0140-6736(93)90417-f
|View full text |Cite
|
Sign up to set email alerts
|

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

43
827
11
24

Year Published

1996
1996
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 1,166 publications
(905 citation statements)
references
References 25 publications
43
827
11
24
Order By: Relevance
“…244 Resistance to rifampicin is almost entirely due to changes in the β subunit of DNA-dependent RNA polymerase, which is encoded by the rpoB gene. 245 Molecular tests targeting this gene are more accurate than using phenotypic DST. 241 However, caution must be used when interpreting data from some molecular tests because not all mutations have the same effect.…”
Section: Genotypic Testingmentioning
confidence: 99%
“…244 Resistance to rifampicin is almost entirely due to changes in the β subunit of DNA-dependent RNA polymerase, which is encoded by the rpoB gene. 245 Molecular tests targeting this gene are more accurate than using phenotypic DST. 241 However, caution must be used when interpreting data from some molecular tests because not all mutations have the same effect.…”
Section: Genotypic Testingmentioning
confidence: 99%
“…Despite the large diversity of mutation patterns globally, only few specific mutations are predominant (Table 2) (Sandgren et al., 2009; Zhang & Yew, 2015). For instance, in the case of rifampicin resistance, hundreds of rpo B mutations have been described (not all were associated with rifampicin resistance), but more than 80% of rifampicin‐resistant isolates display mutations in three codons rpo B531, 526 and 516 (Campbell et al., 2011; Lipin et al., 2007; Pozzi et al., 1999; Telenti et al., 1993). Similar to that, among the approximately 300 mutations found in the kat G gene, the prevalence of kat G S315T mutation can vary between 32% and 95% in isoniazid‐resistant clinical isolates depending on the geographic regions and drug resistance patterns (Hazbon et al., 2006; Lipin et al., 2007; Mokrousov et al., 2002; Vilcheze & Jacobs, 2014).…”
Section: Characteristics and Diversity Of Drug Resistance‐associated mentioning
confidence: 99%
“… Notes aNucleotide change.bSee the following studies for reference (Campbell et al., 2011; Duong et al., 2009; Hazbon et al., 2006; Hillemann et al., 2005; Lipin et al., 2007; Mokrousov et al., 2002; Müller et al., 2011; Niehaus et al., 2015; Perdigao et al., 2010; Pozzi et al., 1999; Qian et al., 2002; Shi et al., 2011; van Soolingen et al., 2000; Sreevatsan et al., 1996, 1997; Telenti et al., 1993; Von Groll et al., 2009). …”
Section: Characteristics and Diversity Of Drug Resistance‐associated unclassified
“…This residue, Ser531 in the M. tuberculosis RpoB protein, was replaced by an Asp in M. kyorinense . Notably, Ser531 is the most frequent location of substitutions in rifampin-resistant strains of M. tuberculosis ( 6 ). …”
mentioning
confidence: 99%